KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) Shares Outstanding (Weighted Average) (2016 - 2025)

Clorox (CLX) has 17 years of Shares Outstanding (Weighted Average) data on record, last reported at $121.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 1.76% year-over-year to $121.6 million; the TTM value through Dec 2025 reached $121.6 million, down 1.76%, while the annual FY2025 figure was $123.5 million, 0.52% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $121.6 million in Q4 2025 per CLX's latest filing, down from $122.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $125.6 million in Q1 2021 and bottomed at $121.6 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $123.6 million, with a median of $123.6 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 2.66% in 2021, then rose 0.51% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $123.1 million in 2021, then rose by 0.31% to $123.4 million in 2022, then increased by 0.51% to $124.1 million in 2023, then decreased by 0.24% to $123.8 million in 2024, then dropped by 1.76% to $121.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $121.6 million in Q4 2025, $122.6 million in Q3 2025, and $123.5 million in Q2 2025.